Free tool
FAERS Monitor: Sezaby
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 215910 or its brand name (Sezaby, Phenobarbital Sodium). Reports on generic versions are filed under their own applications.
Reports
416
Serious
405
97% of reports
Hospitalization
215
Death reported
62
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- seizure68
- off label use60
- drug ineffective58
- epilepsy27
- status epilepticus21
- product use in unapproved indication19
- pallor18
- sepsis18
- drug ineffective for unapproved indication17
- condition aggravated16
- confusional state15
- drug resistance15
- fall15
- pyrexia15
- death14
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 5 |
| 2005 | 6 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 7 |
| 2012 | 6 |
| 2013 | 15 |
| 2014 | 10 |
| 2015 | 12 |
| 2016 | 19 |
| 2017 | 12 |
| 2018 | 50 |
| 2019 | 37 |
| 2020 | 19 |
| 2021 | 34 |
| 2022 | 37 |
| 2023 | 40 |
| 2024 | 41 |
| 2025 | 29 |
| 2026 | 30 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,743 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| status epilepticusSignal | 21 | 94.2 | 62.1 | 1,842 |
| epilepsySignal | 27 | 44.7 | 31.0 | 1,111 |
| pallorSignal | 18 | 33.5 | 21.3 | 535 |
| seizureSignal | 68 | 29.8 | 24.0 | 1,872 |
| drug resistanceSignal | 15 | 29.5 | 18.0 | 386 |
| drug ineffective for unapproved indicationSignal | 17 | 15.7 | 9.8 | 220 |
| sepsisSignal | 18 | 8.2 | 5.2 | 107 |
| confusional stateSignal | 15 | 4.7 | 2.9 | 40 |
| product use in unapproved indicationSignal | 19 | 3.9 | 2.5 | 38 |
| off label useSignal | 60 | 3.5 | 2.7 | 107 |
| condition aggravatedSignal | 16 | 2.7 | 1.6 | 15 |
| fallSignal | 15 | 2.3 | 1.4 | 10 |
| drug ineffectiveSignal | 58 | 2.2 | 1.8 | 40 |
| pyrexiaSignal | 15 | 2.2 | 1.3 | 9 |
| death | 14 | 0.8 | 0.5 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.